Mitf and Tfe3: Members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function

Bone

Volumn 34, Issue 4, 2004, Pages 689-696

  Hershey, Christine L ^a   Fisher, David E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Bone; Mitf; Osteoclasts; Osteopetrosis; Tfe3; Transcription factor

Indexed keywords

MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TFE3; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL INTERACTION; CELL MATURATION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; MAST CELL; MELANOCYTE; NATURAL KILLER CELL; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PIGMENT EPITHELIUM; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; HELIX-LOOP-HELIX MOTIFS; HUMANS; LEUCINE ZIPPERS; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; OSTEOCLASTS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 1642263620     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2003.08.014     Document Type: Review

References (71)

1. Teitelbaum S.L. Bone resorption by osteoclasts. Science. 289:2000;1504-1508.
2. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature. 423:2003;337-342.
3. Hertwig P. Neue Mutationen und Kopplungsgruppen bei der Hausmaus. Z. Indukt. Abstamm.-Vererbungsl. 80:1942;220-246.
4. Roundy K., Kollhoff A., Eichwald E.J., Weis J.J., Weis J.H. Microphthalmic mice display a B cell deficiency similar to that seen for mast and NK cells. J. Immunol. 163:1999;6671-6678.
5. Moore K.J. Insight into the microphthalmia gene. Trends Genet. 11:1995;442-448.
6. Hodgkinson C.A., Moore K.J., Nakayama A., Steingrimsson E., Copeland N.G., Jenkins N.A.et al. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix- zipper protein. Cell. 74:1993;395-404.
7. Hughes M.J., Lingrel J.B., Krakowsky J.M., Anderson K.P. A helix-loop-helix transcription factor-like gene is located at the mi locus. J. Biol. Chem. 268:1993;20687-20690.
8. Hemesath T.J., Steingrimsson E., McGill G., Hansen M.J., Vaught J., Hodgkinson C.A.et al. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 8:1994;2770-2780.
9. Tassabehji M., Newton V.E., Read A.P. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat. Genet. 8:1994;251-255.
10. Amiel J., Watkin P.M., Tassabehji M., Read A.P., Winter R.M. Mutation of the MITF gene in albinism-deafness syndrome (Tietz syndrome). Clin. Dysmorphol. 7:1998;17-20.
11. Price E.R., Fisher D.E. Sensorineural deafness and pigmentation genes: melanocytes and the Mitf transcriptional network. Neuron. 30:2001;15-18.
12. Hallsson J.H., Favor J., Hodgkinson C., Glaser T., Lamoreux M.L., Magnusdottir R.et al. Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus. Genetics. 155:2000;291-300.
13. The Jackson Laboratory-Mouse Genome Informatics, http://www.informatics. jax.org/.
14. Marks S.C. Jr., Walker D.G. The hematogenous origin of osteoclasts: experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors. Am. J. Anat. 161:1981;1-10.
15. Marks S.C. Jr. Pathogenesis of osteopetrosis in the microphthalmic mouse: reduced bone resorption. Am. J. Anat. 149:1977;269-275.
16. Raisz L.G., Simmons H.A., Gworek S.C., Eilon G. Studies on congenital osteopetrosis in microphthalmic mice using organ cultures: impairment of bone resorption in response to physiologic stimulators. J. Exp. Med. 145:1977;857-865.
17. Murphy H.M. The osteopetrotic syndrome in the microphthalmic mutant mouse. Calcif. Tissue Res. 13:1973;19-26.
18. Steingrimsson E., Tessarollo L., Pathak B., Hou L., Arnheiter H., Copeland N.G.et al. Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development. Proc. Natl. Acad. Sci. U. S. A. 99:2002;4477-4482.
19. Al-Douri S.M., Johnson D.R. The development of the teeth of the microphthalmic (mi/mi) mouse. J. Anat. 153:1987;139-149.
20. Holtrop M.E., Cox K.A., Eilon G., Simmons H.A., Raisz L.G. The ultrastructure of osteoclasts in microphthalmic mice. Metab. Bone Dis. Relat. Res. 3:1981;123-129.
21. Packer S.O. The eye and skeletal effects of two mutant alleles at the microphthalmia locus of Mus musculus. J. Exp. Zool. 165:1967;21-46.
22. Thesingh C.W., Scherft J.P. Fusion disability of embryonic osteoclast precursor cells and macrophages in the microphthalmic osteopetrotic mouse. Bone. 6:1985;43-52.
23. Walker D.G. Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells. Science. 190:1975;784-785.
24. Mansky K.C., Marfatia K., Purdom G.H., Luchin A., Hume D.A., Ostrowski M.C. The microphthalmia transcription factor (MITF) contains two N-terminal domains required for transactivation of osteoclast target promoters and rescue of mi mutant osteoclasts. J. Leukoc. Biol. 71:2002;295-303.
25. Luchin A., Purdom G., Murphy K., Clark M., Angel N., Cassady A.I.et al. The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts. J. Bone Miner. Res. 15:2000;451-460.
26. Kawaguchi N., Noda M. Mitf is expressed in osteoclast progenitors in vitro. Exp. Cell Res. 260:2000;284-291.
27. Motyckova G., Weilbaecher K.N., Horstmann M., Rieman D.J., Fisher D.Z., Fisher D.E. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc. Natl. Acad. Sci. U. S. A. 98:2001;5798-5803.
28. Weilbaecher K.N., Motyckova G., Huber W.E., Takemoto C.M., Hemesath T.J., Xu Y.et al. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol. Cell. 8:2001;749-758.
29. Rho J., Altmann C.R., Socci N.D., Merkov L., Kim N., So H.et al. Gene expression profiling of osteoclast differentiation by combined suppression subtractive hybridization (SSH) and cDNA microarray analysis. DNA Cell Biol. 21:2002;541-549.
30. Steingrimsson E., Moore K.J., Lamoreux M.L., Ferre-D'Amare A.R., Burley S.K., Zimring D.C.et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat. Genet. 8:1994;256-263.
31. Nii A., Steingrimsson E., Copeland N.G., Jenkins N.A., Ward J.M. Mild osteopetrosis in the microphthalmia-oak ridge mouse. A model for intermediate autosomal recessive osteopetrosis in humans. Am. J. Pathol. 147:1995;1871-1882.
32. Weilbaecher K.N., Hershey C.L., Takemoto C.M., Horstmann M.A., Hemesath T.J., Tashjian A.H.et al. Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J. Exp. Med. 187:1998;775-785.
33. Opdecamp K., Vanvooren P., Riviere M., Arnheiter H., Motta R., Szpirer J.et al. The rat microphthalmia-associated transcription factor gene (Mitf) maps at 4q34-q41 and is mutated in the mib rats. Mamm. Genome. 9:1998;617-621.
34. Moutier R., Ostrowski K., Lamendin H. Microphthalmia: a new recessive mutation in the Norway rat. J. Hered. 80:1989;76-78.
35. Cielinski M.J., Marks S.C. Jr. Neonatal reductions in osteoclast number and function account for the transient nature of osteopetrosis in the rat mutation microphthalmia blanc (mib). Bone. 15:1994;707-715.
36. di). Genet. Res. Camb. 46:1985;309-324.
37. Kawaguchi N., Ono T., Mochii M., Noda M. Spontaneous mutation in Mitf gene causes osteopetrosis in silver homozygote quail. Dev. Dyn. 220:2001;133-140.
38. Mansky K.C., Sulzbacher S., Purdom G., Nelsen L., Hume D.A., Rehli M.et al. The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter. J. Leukoc. Biol. 71:2002;304-310.
39. Steingrimsson E., Tessarollo L., Reid S.W., Jenkins N.A., Copeland N.G. The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. Development. 125:1998;4607-4616.
40. Rehli M., Lichanska A., Cassady A.I., Ostrowski M.C., Hume D.A. TFEC is a macrophage-restricted member of the microphthalmia TFE subfamily of basic helix-loop-helix leucine zipper transcription factors. J. Immunol. 162:1999;1559-1565.
41. Motyckova G., Fisher D.E. Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease. Curr. Mol. Med. 2:2002;407-421.
42. Udono T., Yasumoto K., Takeda K., Amae S., Watanabe K., Saito H.et al. Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. Biochim. Biophys. Acta. 1491:2000;205-219.
43. Takeda K., Yasumoto K., Kawaguchi N., Udono T., Watanabe K., Saito H.et al. Mitf-D, a newly identified isoform, expressed in the retinal pigment epithelium and monocyte-lineage cells affected by Mitf mutations. Biochim. Biophys. Acta. 1574:2002;15-23.
44. Oboki K., Morii E., Kataoka T.R., Jippo T., Kitamura Y. Isoforms of mi transcription factor preferentially expressed in cultured mast cells of mice. Biochem. Biophys. Res. Commun. 290:2002;1250-1254.
45. Takemoto C.M., Yoon Y.J., Fisher D.E. The identification and functional characterization of a novel mast cell isoform of the microphthalmia-associated transcription factor. J. Biol. Chem. 277:2002;30244-30252.
46. Shibahara S., Takeda K., Yasumoto K., Udono T., Watanabe K., Saito H.et al. Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J. Investig. Dermatol. Symp. Proc. 6:2001;99-104.
47. Mansky K.C., Sankar U., Han J., Ostrowski M.C. Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling. J. Biol. Chem. 277:2002;11077-11083.
48. Sato M., Morii E., Takebayashi-Suzuki K., Yasui N., Ochi T., Kitamura Y.et al. Microphthalmia-associated transcription factor interacts with PU.1 and c-Fos: determination of their subcellular localization. Biochem. Biophys. Res. Commun. 254:1999;384-387.
49. Luchin A., Suchting S., Merson T., Rosol T.J., Hume D.A., Cassady A.I.et al. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J. Biol. Chem. 276:2001;36703-36710.
50. Takebayashi K., Chida K., Tsukamoto I., Morii E., Munakata H., Arnheiter H.et al. The recessive phenotype displayed by a dominant negative microphthalmia-associated transcription factor mutant is a result of impaired nucleation potential. Mol. Cell. Biol. 16:1996;1203-1211.
51. Tondravi M.M., McKercher S.R., Anderson K., Erdmann J.M., Quiroz M., Maki R.et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature. 386:1997;81-84.
52. Grigoriadis A.E., Wang Z.Q., Wagner E.F. Fos and bone cell development: lessons from a nuclear oncogene. Trends Genet. 11:1995;436-441.
53. So H., Rho J., Jeong D., Park R., Fisher D.E., Ostrowski M.C.et al. Microphthalmia transcription factor and PU.1 synergistically induce the leukocyte receptor OSCAR gene expression. J. Biol. Chem. 278:2003;24209-24216.
54. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20:1999;345-357.
55. Lee Z.H., Kim H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Biophys. Res. Commun. 305:2003;211-214.
56. Walsh M.C., Choi Y. Biology of the TRANCE axis. Cytokine Growth Factor Rev. 14:2003;251-263.
57. Mizukami J., Takaesu G., Akatsuka H., Sakurai H., Ninomiya-Tsuji J., Matsumoto K.et al. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol. Cell. Biol. 22:2002;992-1000.
58. Goding C.R. Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev. 14:2000;1712-1728.
59. Widlund H.R., Fisher D.E. Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene. 22:2003;3035-3041.
60. Kitamura Y., Morii E., Jippo T., Ito A. Effect of MITF on mast cell differentiation. Mol. Immunol. 38:2002;1173.
61. Nechushtan H., Razin E. The function of MITF and associated proteins in mast cells. Mol. Immunol. 38:2002;1177.
62. Hayman A.R., Jones S.J., Boyde A., Foster D., Colledge W.H., Carlton M.B.et al. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development. 122:1996;3151-3162.
63. Kim N., Takami M., Rho J., Josien R., Choi Y. A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J. Exp. Med. 195:2002;201-209.
64. McGill G.G., Horstmann M., Widlund H.R., Du J., Motyckova G., Nishimura E.K.et al. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell. 109:2002;707-718.
65. Amling M., Neff L., Tanaka S., Inoue D., Kuida K., Weir E.et al. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J. Cell Biol. 136:1997;205-213.
66. Weilbaecher K.N. Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 6:2000;165-174.
67. Rodan G.A., Martin T.J. Therapeutic approaches to bone diseases. Science. 289:2000;1508-1514.
68. mi-bw) gene: the loss of a single Mitf isoform responsible for the pigmentary defect and inner ear deafness. Hum. Mol. Genet. 8:1999;1431-1441.
69. Steingrimsson E., Arnheiter H., Hallsson J.H., Lamoreux M.L., Copeland N.G., Jenkins N.A. Interallelic complementation at the mouse mitf locus. Genetics. 163:2003;267-276.
70. Steingrimsson E., Nii A., Fisher D.E., Ferre-D'Amare A.R., McCormick R.J., Russell L.B.et al. The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization. EMBO J. 15:1996;6280-6289.
71. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D.et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 11:1997;3482-3496.